Skip to content
OpenCapital
Get started

GoPro GPRO Capitalized research and development costs

Capitalized research and development costs at other companies

IBT
IbottaIBTA
$22.65M-42.0%
ESAB logo
ESABESAB
$22.04M+7.2%
BillionToOne, Inc. logo
BillionToOne, Inc. BLLN
$6.06M-47.2%
BTCS logo
BTCSBTCS
$122.52K-26.2%
Kadant logo
KadantKAI
$3.85M-17.8%
Hubbell logo
HubbellHUBB
$32.5M-42.2%

Other financials

Income statement

See full
Revenue$99.1M-26.2%
Gross profit$4.3M-90.0%
Operating income-$57.2M-26.6%
Net income-$80.8M-73.0%
EPS (diluted)-$0.50-66.7%

Balance sheet

See full
Cash & equivalents$25.2M-7.7%
Total debt$88.7M-39.4%
Total equity-$1.9M-102%
Total assets$381.4M-17.5%

Cash flow

See full
Operating cash flow-$36.6M+36.0%
CapEx$1.0M-20.1%
Free cash flow-$37.7M+35.6%

Valuation

See full
Market cap$124.56M-2.2%
Enterprise value$188.03M-19.1%
P/S0.2×0.0×

Profitability

See full
Gross margin29.3%-4.2pp
Operating margin-15.5%-1.8pp
Net margin-20.7%+3.8pp
FCF margin-11.3%—

Returns & leverage

See full
Return on equity-81.9%-20.3pp
Debt / equity1.4×0.0×
Current ratio0.6×-0.3×

Where this comes from

Reported directly by GoPro in its filing.

Tagged under the XBRL concept gpro:CapitalizedResearchAndDevelopmentCosts.

The official record: GoPro’s 10-K, filed March 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about GoPro's capitalized research and development costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is GoPro's capitalized research and development costs?
GoPro (GPRO) reported capitalized research and development costs of $19.7M in Q4 2025.
What is the long-term trend for GoPro's capitalized research and development costs?
Over 3 years (2022 to 2025), GoPro's capitalized research and development costs has grown at a -12.2% compound annual growth rate (CAGR), from $29.12M to $19.7M.
What does capitalized research and development costs mean?
This represents the portion of research and development expenditures that have been capitalized as assets rather than expensed immediately. It reflects the company's investment in long-term innovation and the expected future economic benefits from its R&D pipeline.